Operator Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator ...

Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...

The best Resident Evil games have been terrifying the generations for over 25 years. Since 1996, The Umbrella Corporation has dominated how we think about zombies and sinister pharmaceutical ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Jeffrey Hatrix, the former frontman for the popular metal band Mushroomhead, has given an update on his cancer battle just weeks after first making the revelation. In a post recently shared by his ...

The full-year 2024 revenue was $394.8 million, a 20% decrease from the previous year. Despite these setbacks, the company continues to lead in the aesthetic market, supported by its extensive ...

ONCE upon a time, “work” meant a boring 9 to 5. Today, in my world, it means Botox, filler, polynucleotides, Profhilo, ...

Your browser does not support the audio element. Before Netflix caused its downfall, the most pressing entertainment dilemma was browsing your local Blockbuster and ...

InMode Ltd (NASDAQ:INMD) reported its financial results for the fourth quarter of 2024, revealing a shortfall in both earnings and revenue compared to market expectations. The company's earnings per ...

For historical reasons, drug discovery programmes for cancer therapy have neglected the possibility that immune reactions might contribute to the efficacy of treatment. For example, since 1976 ...

The federal executive council (FEC) has approved an allocation of N4.5 billion for the procurement of HIV treatment packs to supportNigerians living with HIV/AIDS. The approval by FEC comes after ...